Minnie Malik

Minnie Malik

Auto-generated profile, based on publicly available information

Minnie Malik

Department of Gynecologic Surgery and Obstetrics, Uniformed Services University of the Health Sciences, Bethesda, Maryland

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 1997 in Current Opinion in Biotechnology
Verified
Journal Article
Closed access
RCRufus L Chaney
Rufus L Chaney
MMMinnie Malik
Minnie Malik
YLYin M Li
Yin M Li
SBSally L Brown
Sally L Brown
EBEric P Brewer
Eric P Brewer
ABAlan Jm Baker
Alan Jm Baker

14 September 2004 in Journal of Agricultural and Food Chemistry
Verified
Journal Article
Closed access
CZCuiwei Zhao
Cuiwei Zhao
M. Monica GiustiM. Monica Giusti
M. Monica Giusti
MMMinnie Malik
Minnie Malik
MMMary P. Moyer
Mary P. Moyer
BMBernadene A. Magnuson
Bernadene A. Magnuson

1 January 2006 in Nutrition and Cancer
Verified
Journal Article
Closed access
GLGeeta Lala
Geeta Lala
MMMinnie Malik
Minnie Malik
CZCuiwei Zhao
Cuiwei Zhao
JHJian He
Jian He
YKYoungjoo Kwon
Youngjoo Kwon
BMBernadene A. Magnuson
Bernadene A. Magnuson
The aim of the present study was to investigate the chemoprotective activity of anthocyanin-rich extracts (AREs) from bilberry (Vaccinium myrtillus L.), chokeberry (Aronia meloncarpa E.), and grape (Vitis vinifera) by assessing multiple biomarkers of colon cancer in male rats treated with a colon carcinogen, azoxymethane. Fischer 344 male rats were fed the AIN-93 diet (control) or AIN-93 diet supplemented with AREs for 14 wk. Biomarkers that were evaluated included the number and multiplicity of colonic aberrant crypt foci (ACF), colonic cell proliferation, urinary levels of oxidative DNA damage, and expression of cyclooxygenase (COX) genes. To assess the bioavailability, levels of anthocyanins in serum, urine, and feces were evaluated. Total ACF were reduced (P < 0.05) in bilberry, chokeberry, and grape diet groups compared with the control group. The number of large ACF was also reduced (P < 0.05) in bilberry and chokeberry ARE-fed rats. Colonic cellular proliferation was decreased in rats fed...

1 July 2003 in Nutrition and Cancer
Verified
Journal Article
Closed access
MMMinnie Malik
Minnie Malik
CZCuiwei Zhao
Cuiwei Zhao
NSNorberta Schoene
Norberta Schoene
M. Monica GiustiM. Monica Giusti
M. Monica Giusti
MMMary P. Moyer
Mary P. Moyer
BMBernadene A. Magnuson
Bernadene A. Magnuson
Anthocyanin-rich extracts, potent antioxidants and commercially available food coloring agents, have been reported to inhibit growth of various cancer cell lines. We investigated the effect of semipurified anthocyanin-rich extract from fruits of Aronia meloncarpa, on normal colon and colon cancer cell lines. A 24-h exposure to 50 µg monomeric anthocyanin/ml of Aronia extract resulted in 60% growth inhibition of human HT-29 colon cancer cells. The treated cells showed a blockage at G1/G0 and G2/M phases of the cell cycle. The cell cycle arrest coincided with an increased expression of the p21WAF1 and p27KIP1 genes and decreased expression of cyclin A and B genes. Prolonged exposure to the extract resulted in no further change in the cell number, indicating a cytostatic inhibition of cell growth. NCM460 normal colon cells demonstrated <10% growth inhibition at the highest concentration of 50 µg/ml extract. A 35% decrease in the cyclooxygenase-2 gene expression was observed within 24 h of exposure of HT-29 c...

30 December 2009 in Reproductive Sciences
Verified
Journal Article
Closed access
PDF file
JNJohn M. Norian
John M. Norian
MMMinnie Malik
Minnie Malik
CPCandace Y. Parker
Candace Y. Parker
DJDoina Joseph
Doina Joseph
PLPhyllis C. Leppert
Phyllis C. Leppert
WCWilliam H. Catherino
William H. Catherino

22 April 2010 in Seminars in Reproductive Medicine
Verified
Journal Article
Closed access
PDF file
MMMinnie Malik
Minnie Malik
JNJohn Norian
John Norian
DMDesirée McCarthy-Keith
Desirée McCarthy-Keith
JBJoy Britten
Joy Britten
WCWilliam H Catherino
William H Catherino
Uterine leiomyomas are highly prevalent and symptomatic tumors of women in their reproductive years. The morbidity caused by these tumors is directly related to increasing size. Leiomyoma cells do not rapidly proliferate; instead, the tumors grow primarily due to excessive production of disorganized extracellular matrix (ECM). The aberrant ECM results from excessive production of collagen subtypes and proteoglycans, increased profibrotic cytokines including transforming growth factors β1 and β3, and decreased or disrupted matrix metalloproteinases. These alterations result in the development of an ECM that is exceptionally stable. As a result, therapeutic interventions must redirect leiomyoma cells toward extracellular matrix dissolution, rather than solely inhibiting cell proliferation. Gonadotropin-releasing hormone analogues and selective progesterone receptor modulators with demonstrated clinical efficacy provide such a change in abnormal extracellular matrix formation by leiomyoma cells, inhibiting and reversing the fibrotic process. Novel therapies using pathways distinct from gonadal hormones, including antifibrotics, retinoic acid, peroxisome-proliferator-activated receptor γ ligands, and curcumin, provide promise for a future with improved therapeutic options for women suffering from uterine leiomyomas.